193 related articles for article (PubMed ID: 31662475)
1. An allosteric PGAM1 inhibitor effectively suppresses pancreatic ductal adenocarcinoma.
Wen CL; Huang K; Jiang LL; Lu XX; Dai YT; Shi MM; Tang XM; Wang QB; Zhang XD; Wang PH; Li HT; Ruan XX; Wang LW; Wang XJ; Wang Q; Lu W; Xiang XQ; Sun X; Xu YH; Lai LH; Zhan Q; Li HW; Peng CH; Chen J; Huang JY; Ye DY; Chen SJ; Chen Z; Li M; Fang Y; Shen BY; Zhou L
Proc Natl Acad Sci U S A; 2019 Nov; 116(46):23264-23273. PubMed ID: 31662475
[TBL] [Abstract][Full Text] [Related]
2. Phosphoglycerate Mutase 1 (PGAM1) Promotes Pancreatic Ductal Adenocarcinoma (PDAC) Metastasis by Acting as a Novel Downstream Target of the PI3K/Akt/mTOR Pathway.
Liu X; Tan X; Liu P; Wu Y; Qian S; Zhang X
Oncol Res; 2018 Aug; 26(7):1123-1131. PubMed ID: 29386088
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of anthraquinone derivatives as allosteric phosphoglycerate mutase 1 inhibitors for cancer treatment.
Huang K; Jiang L; Liang R; Li H; Ruan X; Shan C; Ye D; Zhou L
Eur J Med Chem; 2019 Apr; 168():45-57. PubMed ID: 30798052
[TBL] [Abstract][Full Text] [Related]
4. A Novel Allosteric Inhibitor of Phosphoglycerate Mutase 1 Suppresses Growth and Metastasis of Non-Small-Cell Lung Cancer.
Huang K; Liang Q; Zhou Y; Jiang LL; Gu WM; Luo MY; Tang YB; Wang Y; Lu W; Huang M; Zhang SZ; Zhuang GL; Dai Q; Shen QC; Zhang J; Lei HM; Zhu L; Ye DY; Chen HZ; Zhou L; Shen Y
Cell Metab; 2019 Dec; 30(6):1107-1119.e8. PubMed ID: 31607564
[TBL] [Abstract][Full Text] [Related]
5. Identification of human phosphoglycerate mutase 1 (PGAM1) inhibitors using hybrid virtual screening approaches.
Yousaf N; Alharthy RD; Maryam ; Kamal I; Saleem M; Muddassar M
PeerJ; 2023; 11():e14936. PubMed ID: 37051414
[TBL] [Abstract][Full Text] [Related]
6. The role of phosphoglycerate mutase 1 in tumor aerobic glycolysis and its potential therapeutic implications.
Jiang X; Sun Q; Li H; Li K; Ren X
Int J Cancer; 2014 Nov; 135(9):1991-6. PubMed ID: 24285383
[TBL] [Abstract][Full Text] [Related]
7. Development of Anthraquinone Analogues as Phosphoglycerate Mutase 1 Inhibitors.
Huang K; Jiang L; Li H; Ye D; Zhou L
Molecules; 2019 Feb; 24(5):. PubMed ID: 30818883
[TBL] [Abstract][Full Text] [Related]
8. Xanthone derivatives as phosphoglycerate mutase 1 inhibitors: Design, synthesis, and biological evaluation.
Wang P; Jiang L; Cao Y; Zhang X; Chen B; Zhang S; Huang K; Ye D; Zhou L
Bioorg Med Chem; 2018 May; 26(8):1961-1970. PubMed ID: 29530347
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D
Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of 1,3,6,7-tetrahydroxyxanthone derivatives as phosphoglycerate mutase 1 inhibitors.
Jiang K; Gao B; Yu J; Jiang L; Niu A; Jia Y; Meng T; Zhou L; Wang J
Bioorg Med Chem Lett; 2021 Mar; 36():127820. PubMed ID: 33513389
[TBL] [Abstract][Full Text] [Related]
11. In silico-based identification of phytochemicals as novel human phosphoglycerate mutase 1 (PGAM1) inhibitors for cancer therapy.
Kanwal N; Rasul A; Shah MA; Jabeen F; Sultana T
Pak J Pharm Sci; 2021 Mar; 34(2(Supplementary)):665-670. PubMed ID: 34275800
[TBL] [Abstract][Full Text] [Related]
12. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K
Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027
[TBL] [Abstract][Full Text] [Related]
13. Phosphoglycerate mutase 1 in cancer: A promising target for diagnosis and therapy.
Sharif F; Rasul A; Ashraf A; Hussain G; Younis T; Sarfraz I; Chaudhry MA; Bukhari SA; Ji XY; Selamoglu Z; Ali M
IUBMB Life; 2019 Oct; 71(10):1418-1427. PubMed ID: 31169978
[TBL] [Abstract][Full Text] [Related]
14. Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice.
Jiang SH; Li J; Dong FY; Yang JY; Liu DJ; Yang XM; Wang YH; Yang MW; Fu XL; Zhang XX; Li Q; Pang XF; Huo YM; Li J; Zhang JF; Lee HY; Lee SJ; Qin WX; Gu JR; Sun YW; Zhang ZG
Gastroenterology; 2017 Jul; 153(1):277-291.e19. PubMed ID: 28315323
[TBL] [Abstract][Full Text] [Related]
15. PGAM1 Inhibition Promotes HCC Ferroptosis and Synergizes with Anti-PD-1 Immunotherapy.
Zheng Y; Wang Y; Lu Z; Wan J; Jiang L; Song D; Wei C; Gao C; Shi G; Zhou J; Fan J; Ke A; Zhou L; Cai J
Adv Sci (Weinh); 2023 Oct; 10(29):e2301928. PubMed ID: 37705495
[TBL] [Abstract][Full Text] [Related]
16. Metabolic shift to serine biosynthesis through 3-PG accumulation and PHGDH induction promotes tumor growth in pancreatic cancer.
Itoyama R; Yasuda-Yoshihara N; Kitamura F; Yasuda T; Bu L; Yonemura A; Uchihara T; Arima K; Hu X; Jun Z; Okamoto Y; Akiyama T; Yamashita K; Nakao Y; Yusa T; Kitano Y; Higashi T; Miyata T; Imai K; Hayashi H; Yamashita YI; Mikawa T; Kondoh H; Baba H; Ishimoto T
Cancer Lett; 2021 Dec; 523():29-42. PubMed ID: 34508795
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic cancer-derived organoids - a disease modeling tool to predict drug response.
Frappart PO; Walter K; Gout J; Beutel AK; Morawe M; Arnold F; Breunig M; Barth TF; Marienfeld R; Schulte L; Ettrich T; Hackert T; Svinarenko M; Rösler R; Wiese S; Wiese H; Perkhofer L; Müller M; Lechel A; Sainz B; Hermann PC; Seufferlein T; Kleger A
United European Gastroenterol J; 2020 Jun; 8(5):594-606. PubMed ID: 32213029
[TBL] [Abstract][Full Text] [Related]
18. Recapitulating the clinical scenario of BRCA-associated pancreatic cancer in pre-clinical models.
Golan T; Stossel C; Atias D; Buzhor E; Halperin S; Cohen K; Raitses-Gurevich M; Glick Y; Raskin S; Yehuda D; Feldman A; Schvimer M; Friedman E; Karni R; Wilson JM; Denroche RE; Lungu I; Bartlett JMS; Mbabaali F; Gallinger S; Berger R
Int J Cancer; 2018 Jul; 143(1):179-183. PubMed ID: 29396858
[TBL] [Abstract][Full Text] [Related]
19. Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal adenocarcinoma.
Wong MH; Xue A; Julovi SM; Pavlakis N; Samra JS; Hugh TJ; Gill AJ; Peters L; Baxter RC; Smith RC
Clin Cancer Res; 2014 Aug; 20(15):4047-58. PubMed ID: 24895459
[TBL] [Abstract][Full Text] [Related]
20. Generation and application of patient-derived xenograft models in pancreatic cancer research.
Wang CF; Shi XJ
Chin Med J (Engl); 2019 Nov; 132(22):2729-2736. PubMed ID: 31725451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
